MENU
+Compare
EYPT
Stock ticker: NASDAQ
AS OF
Apr 3, 04:59 PM (EDT)
Price
$4.97
Change
-$0.40 (-7.45%)
Capitalization
342.27M

EYPT EyePoint Pharmaceuticals Forecast, Technical & Fundamental Analysis

EyePoint Pharmaceuticals Inc is a pharmaceutical company... Show more

EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for EYPT with price predictions
Apr 02, 2025

EYPT's RSI Indicator ascending out of oversold territory

The RSI Oscillator for EYPT moved out of oversold territory on April 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In of the 39 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EYPT advanced for three days, in of 261 cases, the price rose further within the following month. The odds of a continued upward trend are .

EYPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EYPT as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for EYPT turned negative on March 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

EYPT moved below its 50-day moving average on March 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EYPT entered a downward trend on March 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.017) is normal, around the industry mean (13.260). P/E Ratio (0.000) is within average values for comparable stocks, (64.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.878). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (6.481) is also within normal values, averaging (252.036).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EYPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EYPT is expected to report earnings to rise 5.27% to -67 cents per share on April 30

EyePoint Pharmaceuticals EYPT Stock Earnings Reports
Q1'25
Est.
$-0.67
Q4'24
Missed
by $0.14
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.04
Q1'24
Missed
by $0.16
The last earnings report on March 05 showed earnings per share of -63 cents, missing the estimate of -50 cents. With 928.84K shares outstanding, the current market capitalization sits at 342.27M.
A.I. Advisor
published General Information

General Information

a developer of ophthalmic pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 617 926-5000
Employees
121
Web
https://www.eyepointpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIIRX25.07N/A
N/A
Nuveen Core Equity A
RLCAX8.42N/A
N/A
Columbia Disciplined Value A
EFCIX19.47N/A
N/A
Emerald Insights Institutional
JFCCX31.14N/A
N/A
JHancock Fundamental All Cap Core C
PMDHX17.96N/A
N/A
Principal Small-MidCap Dividend Inc R6

EYPT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+6.34%
LYRA - EYPT
58%
Loosely correlated
-2.91%
OCUL - EYPT
54%
Loosely correlated
+12.23%
ATHE - EYPT
54%
Loosely correlated
-2.52%
GLYC - EYPT
46%
Loosely correlated
+4.28%
BEAM - EYPT
42%
Loosely correlated
+4.79%
More